前收市價 | 0.0100 |
開市 | 0.0100 |
買盤 | 0.0000 |
賣出價 | 0.0200 |
拍板 | 2.50 |
到期日 | 2024-07-19 |
今日波幅 | 0.0100 - 0.0200 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 1.06k |
Novavax (NVAX) seeks marketing authorization in the European Union for an updated version of its COVID-19 vaccine, which has been formulated to target the JN.1 variant.
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Novavax stock seesawed on June 6 after the FDA assigned an April review date for its Covid vaccine. Is NVAX stock a buy right now?